申请人:Gyorkos Charles Albert
公开号:US20070179165A1
公开(公告)日:2007-08-02
There is provided a CRF receptor antagonist comprising a compound of the formula (I):
A-W—Ar (I)
wherein, A is a group represented by the formula (A1) or (A2):
(wherein, ring Aa is a 5- or 6-membered ring which may be further substituted; ring Ab is a 5- or 6-membered ring which may be further substituted; ring Ac is a 5- or 6-membered ring which may be substituted; R
1
is optionally substituted alkyl, substituted amino, substituted hydroxy, etc.; X is carbonyl, —O—, —S—, etc.; Y
1
, Y
2
and Q are independently optionally substituted carbon or nitrogen;
is a single or double bond); W is a bond, optionally substituted methylene, optionally substituted imino, —O—, —S—, etc.; Ar is optionally substituted aryl or optionally substituted heteroaryl; or a salt thereof or a prodrug thereof.
提供了一种CRF受体拮抗剂,包括式(I)的化合物:A-W-Ar(I),其中,A是由式(A1)或(A2)表示的基团:(其中,环Aa是一个可以进一步取代的5-或6成员环;环Ab是一个可以进一步取代的5-或6成员环;环Ac是一个可以取代的5-或6成员环;R1是可选的取代基的烷基,取代的氨基,取代的羟基等;X是羰基,-O-,-S-等;Y1,Y2和Q独立地是可选取代的碳或氮;是单键或双键);W是键,可选取代的亚甲基,可选取代的亚胺基,-O-,-S-等;Ar是可选取代的芳基或可选取代的杂芳基;或其盐或前药。